限制性股票激励计划
Search documents
安达智能: 监事会关于2024年限制性股票激励计划预留授予第二类限制性股票第一个归属期归属名单的核查意见
Zheng Quan Zhi Xing· 2025-08-29 17:35
Core Points - The company has reviewed the list of eligible participants for the first vesting period of the second category of restricted stock under the 2024 restricted stock incentive plan [1][2] - A total of 13 individuals have been identified as eligible participants, all meeting the qualifications set forth by relevant laws and regulations [1] - The total number of restricted stocks to be vested corresponds to 212,320 shares, which complies with legal and regulatory requirements and does not harm the interests of the company and its shareholders [2] Summary by Sections - **Eligibility of Participants** - The company confirmed that all 13 participants meet the qualifications as per the Company Law and Securities Law [1] - The participants also satisfy the conditions outlined in the Management Measures and Listing Rules [1] - **Vesting Details** - The total number of shares to be vested is 212,320 [2] - The vesting conditions for the restricted stocks have been fulfilled [1][2] - **Compliance and Interests** - The actions taken are in accordance with relevant laws and regulations, ensuring no detriment to the company or its shareholders [2]
宇瞳光学: 关于召开2025年第二次临时股东大会的通知
Zheng Quan Zhi Xing· 2025-08-29 17:35
Meeting Overview - The company will hold its second extraordinary general meeting of shareholders for 2025 on September 15, 2025, at 14:30 [1] - Shareholders can participate through on-site voting or online voting via the Shenzhen Stock Exchange trading system [2] Voting Procedures - Shareholders must choose one voting method: on-site, trading system, or internet voting, with the first vote counted in case of duplicates [2] - All shareholders registered by the cut-off date of September 8, 2025, are eligible to attend and vote [2] Agenda Items - The meeting will discuss various proposals, including the 2025 semi-annual profit distribution plan and amendments to corporate governance rules [9] - Proposals related to the 2025 restricted stock incentive plan and employee stock ownership plan will also be presented for approval [3][9] Registration and Attendance - Registration for attending the meeting must be completed by September 12, 2025, with specific documentation required for both corporate and individual shareholders [4] - The meeting will last half a day, and attendees are responsible for their own travel and accommodation costs [4] Online Voting Instructions - Detailed instructions for participating in online voting are provided, including the need for identity verification through the trading system [6]
英诺特: 关于召开2025年第一次临时股东大会的通知
Zheng Quan Zhi Xing· 2025-08-29 17:35
Group 1 - The company will hold its 2025 First Extraordinary General Meeting on September 15, 2025, at 14:45 in Beijing [2][6] - Voting will be conducted through a combination of on-site and online methods, with specific time slots for each [1][2] - The agenda includes several non-cumulative voting proposals, such as changes to registered capital and the implementation of a stock incentive plan [2][8] Group 2 - The company will utilize the Shanghai Stock Exchange's network voting system for shareholder participation [2][4] - Shareholders must register for the meeting by providing necessary documentation, including identity verification [5][6] - The company aims to enhance participation from small and medium investors by offering reminder services for the meeting [4][6]
圣邦股份: 北京市君合律师事务所关于圣邦微电子(北京)股份有限公司2023年股票期权激励计划首次授予第二个行权期及预留授予第一个行权期可行权等事项的法律意见书
Zheng Quan Zhi Xing· 2025-08-29 17:34
Core Viewpoint - The legal opinion letter issued by JunHe Law Offices confirms that the actions related to the stock option incentive plans of Shengbang Microelectronics (Beijing) Co., Ltd. have received the necessary approvals and comply with relevant regulations [5][14][15]. Group 1: Approval and Authorization - The board of directors and the supervisory board have approved the actions regarding the exercise of stock options, cancellation of stock options, and invalidation of restricted stocks [5][14]. - The shareholders' meeting has authorized the board to handle matters related to the 2021 and 2023 incentive plans [5][6]. Group 2: Details of the Exercise - The second exercise period of the 2023 stock option incentive plan allows 1,041 participants to exercise a total of 2,462,803 stock options at a price of 50.54 yuan per option [7][10]. - The first exercise period of the reserved grant allows 460 participants to exercise a total of 576,147 stock options at a price of 44.46 yuan per option [8][10]. Group 3: Conditions for Exercise - The conditions for exercising the stock options have been met, including no negative audit opinions and compliance with performance assessment requirements [10][11]. - The performance target for the first exercise period corresponds to a revenue target of 3 billion yuan for 2024 [12]. Group 4: Cancellation of Stock Options - A total of 34,523 stock options will be canceled due to the departure of seven participants and performance assessments that did not meet the required standards [13][14]. - The cancellation aligns with the provisions of the 2023 incentive plan regarding the treatment of stock options when participants leave the company [13][14]. Group 5: Invalidation of Restricted Stocks - A total of 40,906 shares of restricted stock will be invalidated due to the departure of 17 participants and failure to meet vesting conditions [15]. - The invalidation is consistent with the 2021 incentive plan's regulations regarding the treatment of restricted stocks [15].
迈普医学: 关于2024年限制性股票激励计划首次授予部分第一个归属期归属条件成就的公告
Zheng Quan Zhi Xing· 2025-08-29 17:34
Core Viewpoint - The announcement details the implementation of the 2024 Restricted Stock Incentive Plan by Guangzhou Maipu Medical Technology Co., Ltd, highlighting the first grant of restricted stocks and the conditions for their vesting [1][2][4]. Summary by Sections Incentive Plan Overview - The 2024 Restricted Stock Incentive Plan involves granting a total of 576,000 restricted shares, representing approximately 0.87% of the company's total share capital as of the plan's announcement date [2]. - The initial grant consists of 461,000 shares, accounting for about 0.70% of the total share capital, while 115,000 shares are reserved, representing 0.17% [2]. Granting and Vesting Conditions - The plan includes 28 core technical and business personnel as recipients, excluding independent directors and major shareholders [2]. - The vesting schedule is structured into three phases: 30% after 12 months, 30% after 24 months, and 40% after 36 months from the grant date [6][7]. Performance Assessment - The performance assessment for the incentive plan is based on annual revenue growth targets for the years 2024 to 2026, with specific percentage goals set for each year [9][10]. - The company must achieve a minimum revenue growth rate to trigger the vesting of shares, with the first year's target set at 23% [9]. Approval and Compliance - The plan has undergone necessary approvals from the board and supervisory committee, confirming that the vesting conditions have been met for the first grant [12][17]. - Legal opinions affirm that the plan complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [18][19]. Adjustments and Pricing - The grant price for the restricted shares has been adjusted from 22.80 RMB to 22.20 RMB per share due to corporate actions such as cash dividends [15].
迈普医学: 关于2023年限制性股票激励计划首次授予部分第二个归属期归属条件成就的公告
Zheng Quan Zhi Xing· 2025-08-29 17:34
Core Viewpoint - The announcement details the achievement of the second vesting condition for the restricted stock incentive plan of Guangzhou Maipu Medical Technology Co., Ltd, indicating that the conditions for vesting have been met for 41 eligible participants, allowing for the allocation of 437,691 shares [14][22]. Summary by Sections Incentive Plan Overview - The 2023 restricted stock incentive plan involves granting 1,868,000 shares, representing approximately 2.83% of the company's total share capital as of the plan's announcement date [2]. - The first grant consists of 1,768,000 shares (2.68% of total capital), while 100,000 shares are reserved for future grants (0.15% of total capital) [2]. Grant and Vesting Conditions - The vesting period for the first grant starts 12 months after the grant date and lasts up to 60 months, with specific performance conditions tied to company revenue growth [3][4]. - The vesting schedule includes three phases: 30% after 12 months, 30% after 24 months, and 40% after 36 months from the grant date [5][6]. Performance Assessment - The performance targets for the incentive plan are based on annual revenue growth rates, with specific thresholds set for each year from 2023 to 2025 [8][17]. - The company must achieve a minimum revenue growth of 12% in the first year, 36% in the second year, and 72% in the third year to meet the vesting conditions [8][18]. Approval and Compliance - The plan has undergone necessary approvals from the board and supervisory committee, confirming that all conditions for the second vesting period have been met [10][22]. - Legal opinions affirm that the plan complies with relevant laws and regulations, ensuring no harm to the interests of the company or its shareholders [21][22]. Shareholder Impact - The total number of shares available for vesting represents 0.66% of the company's total share capital, reflecting the company's commitment to aligning employee incentives with shareholder interests [20][22]. - The adjusted grant price for the restricted stock is set at 19.80 RMB per share, following previous adjustments due to corporate actions [19][22].
瑞松科技: 北京市中伦(广州)律师事务所关于广州瑞松智能科技股份有限公司2025年限制性股票激励计划调整公司层面业绩考核指标事项的法律意见书
Zheng Quan Zhi Xing· 2025-08-29 17:34
Core Viewpoint - The legal opinion letter addresses the adjustment of performance assessment indicators for the 2025 restricted stock incentive plan of Guangzhou Ruisheng Intelligent Technology Co., Ltd. [1][2][4] Group 1: Approval and Authorization of Adjustments - The adjustments to the performance assessment indicators have been approved and authorized by the company's board of directors, in accordance with relevant laws and regulations [7][8][10] - The adjustments are necessary to ensure the smooth implementation of the incentive plan and to motivate the company's team effectively [12][13] Group 2: Specific Adjustments to Performance Indicators - The performance assessment for the incentive plan will now include both net profit growth rate and non-recurring net profit growth rate, with 2024 as the base year [16][17] - The adjusted performance targets for the first vesting period in 2025 are set at a target value of 170% and a trigger value of 140% for net profit growth rate [15][17] - For the second vesting period in 2026, the target value is set at 260% and the trigger value at 230% for net profit growth rate [15][17] Group 3: Compliance and Conclusion - The adjustments comply with the relevant regulations and do not harm the interests of the company and its shareholders [19][20] - The adjustments still require approval from the company's shareholders' meeting to be fully enacted [19][20]
金盘科技: 关于作废部分已授予尚未归属的2021年限制性股票的公告
Zheng Quan Zhi Xing· 2025-08-29 17:25
证券代码:688676 证券简称:金盘科技 公告编号:2025-059 海南金盘智能科技股份有限公司 关于作废部分已授予尚未归属的 2021 年限制性股票的公 告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 海南金盘智能科技股份有限公司(以下简称"公司")于 2025 年 8 月 28 日召开第 三届董事会第二十六次会议,审议通过了《关于作废部分已授予尚未归属的 2021 年限 制性股票的议案》。根据公司 2021 年限制性股票激励计划规定,各归属期对激励对象 需进行绩效考核,所授予但尚未归属的限制性股票将予以作废处理。现将有关事项说明 如下: 一、本次激励计划已履行的决策程序和信息披露情况 (一)2021 年 9 月 23 日,公司召开第二届董事会第十四次会议,审议通过了《关 于 <公司 ensp="ensp" 年限制性股票激励计划="年限制性股票激励计划" 草案="草案"> 及其摘要的议 案》、《关于 <公司 ensp="ensp"> 年限制性股票激励计划实施考核管理办法>的议案》《关于提请股东大会授权董事会办 理 ...
金盘科技: 2025年限制性股票激励计划首次授予激励对象名单
Zheng Quan Zhi Xing· 2025-08-29 17:25
Core Points - The company has implemented a restricted stock incentive plan, distributing a total of 500,000 shares, which represents 1.089% of the company's total equity at the time of the announcement [1][2] - The plan includes two categories of incentive recipients: A Class (executives and core technical personnel) and B Class (mid-level management and key business personnel) [1] - A total of 400,000 shares, or 80% of the plan, are initially granted, with an additional 100,000 shares reserved for future allocation [1] Distribution Details - A Class recipients include executives and core technical personnel, while B Class consists of 17 mid-level managers and key personnel [1] - The shares allocated to B Class recipients amount to 12,200 shares, which is 2.44% of the total shares granted [1] - The reserved portion of the plan accounts for 20% of the total shares, equating to 100,000 shares [1]
金盘科技: 2025年限制性股票激励计划实施考核管理办法
Zheng Quan Zhi Xing· 2025-08-29 17:25
Core Viewpoint - The company has developed a restrictive stock incentive plan for 2025 to attract and retain talent, aligning the interests of shareholders, the company, and employees for long-term development [1][2] Group 1: Purpose and Principles of the Assessment - The purpose of the assessment is to establish a long-term incentive mechanism to attract and retain talent while aligning the interests of shareholders, the company, and employees [2] - The assessment is based on principles that ensure shareholder interests are protected, following relevant laws and regulations [2] Group 2: Assessment Organization - The Compensation and Assessment Committee is responsible for leading and organizing the assessment of incentive participants [2] - A dedicated assessment team will be formed to implement the assessment, reporting to the Compensation and Assessment Committee [2] Group 3: Assessment Scope - The assessment applies to all participants in the stock incentive plan, including senior management, core technical personnel, and key business staff [2][3] Group 4: Assessment Indicators and Standards - The performance assessment for the company will be based on revenue and net profit targets for the years 2025 to 2027 [3][4] - Specific targets include: - 2025: Revenue of 86.25 billion and net profit of 7.19 billion - 2026: Revenue of 103.50 billion and net profit of 8.63 billion - 2027: Revenue of 124.20 billion and net profit of 10.35 billion [4] Group 5: Personal Performance Assessment - Individual performance will be assessed based on internal criteria, with results categorized into six levels, affecting the personal share of stock [4] Group 6: Assessment Procedures and Results Management - The assessment team will maintain records and submit performance reports to the Compensation and Assessment Committee [4][5] - Assessment results will be communicated to participants within five working days, with an option for appeal [4][5] Group 7: Additional Provisions - The board of directors is responsible for the formulation, interpretation, and revision of the assessment methods [6] - The plan will be implemented after approval by the shareholders' meeting [6]